Clinical Trials Browser

Has announcements × Gastrointestinal Stromal Tumors × ripretinib × Clear all

NCT03353753 2022-11-21

INVICTUS

Phase 3 Completed

129 enrolled 19 charts 1 FDA

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors